Summary

Based on Triton’s research report, the Latin America surgical site infection control market is estimated to advance in revenue at a CAGR of 5.06% during the forecast period 2024-2032.
The surgical site infection control market in Latin America is supported largely by increasing awareness of healthcare-associated infections (HAIs) and the implementation of stringent infection control measures by healthcare authorities. According to WHO, SSIs are among the most common HAIs. This has prompted governments and healthcare institutions to enhance their focus on infection prevention protocols. For instance, Brazil’s National Health Surveillance Agency (ANVISA) has introduced stringent guidelines for sterilization and hygiene practices in hospitals. Additionally, initiatives by organizations like the Pan American Health Organization (PAHO) aim to reduce the incidence of SSIs by promoting sterilization techniques across healthcare settings. These efforts have led to a gradual but significant improvement in surgical site infection management, creating a favorable environment for players in the studied market.
The countries evaluated in this region include Mexico, Brazil, and Rest of Latin America.
Brazil captures the highest market share in the region, attaining $119.3 million in 2023
• The Brazilian government has implemented several policies to improve infection control in healthcare settings. The Ministry of Health’s ‘National Plan for Hospital Infection Control’ mandates that all hospitals implement effective infection control programs. The ANVISA has also issued stringent regulations for sterilization practices and hospital hygiene, contributing significantly to the market’s growth.

• Accreditation programs such as the ONA (Organização Nacional de Acreditação) and the JCI (Joint Commission International) are becoming increasingly popular in Brazil. Hospitals seeking these accreditations must comply with stringent infection control standards, including SSI prevention.

• As per ONA, a healthcare organization seeking level 1 accreditation should meet the quality and safety standards by 70% or more. The increase in hospitals pursuing these accreditations has led to higher adoption of measures to prevent surgical site infections, which contributes substantially to the market’s progression.
Market Forecast for Mexico
The surgical site infection control market in Mexico is accelerated by increasing awareness and regulatory initiatives aimed at improving patient outcomes in hospitals and healthcare facilities. According to industry sources, surgical site infection rates in Mexico are significantly higher than those reported in developed countries, underscoring the urgent need for enhanced infection control measures. This has compelled both public and private healthcare sectors to invest in advanced infection prevention technologies and protocols.
Moreover, government initiatives, such as the implementation of the National Health Security Strategy, are playing a crucial role. This emphasizes the adoption of best practices for infection control and the utilization of modern sterilization techniques, further fueling demand for surgical site infection control products and services.
The market is sectioned based on procedure, industry vertical, type of infection, and product. The procedure section includes cardiovascular, laparoscopy, orthopedic surgery, wound closure, obstetrics and gynecology, thoracic surgery, plastic & reconstructive surgery, microvascular, neurosurgery, urology, and other procedures.
Cardiovascular surgery addresses heart-related conditions such as ischemic heart disease, valvular heart disease, and congenital heart defects and also encompasses heart transplantation. The instruments used in these surgeries include clamps, cutting devices, needle holders, retractors, scalpels, vascular dilators, forceps, and powered tools like sternal saws. Valve surgery instruments, such as hooks, suture-holding frames, and valve dilators, are also essential. To prevent surgical site infections, specialized control products are utilized throughout the procedure, ensuring a sterile environment and reducing the risk of complications.
Contender Analysis in the Surgical Site Infection Control Market:
Steris Corporation is a leading provider of infection prevention and procedural products and services, catering primarily to healthcare, pharmaceutical, and medical device industries. The company offers a distinctive combination of innovative products and services, ranging from equipment installation and maintenance to microbial reduction for medical devices. It operates through several business segments: healthcare specialty services, healthcare products, life sciences, and applied sterilization technologies. The healthcare products segment focuses on infection prevention and procedural solutions for healthcare providers. The healthcare specialty services segment provides hospital sterilization, instrument and scope repairs, and linen management.
Other major companies in the market include Gama Healthcare, Johnson & Johnson, Kimberly-Clark Corporation, Stryker Corporation, and Sotera Health LLC.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT ANALYSIS ON THE SURGICAL SITE INFECTION CONTROL MARKET
2.1.1. COVID-19 IMPACT
2.2. PORTER’S FIVE FORCES ANALYSIS
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTES
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. THREAT OF COMPETITIVE RIVALRY
2.3. KEY MARKET STRATEGIES
2.3.1. PRODUCT LAUNCHES
2.3.2. ACQUISITIONS
2.3.3. BUSINESS DIVESTITURES & EXPANSIONS
2.4. MARKET DRIVERS
2.4.1. ESCALATING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
2.4.2. GROWING GERIATRIC POPULATION
2.4.3. REGULATORY GUIDELINES FOR PREVENTING HOSPITAL-ACQUIRED INFECTION
2.5. MARKET CHALLENGES
2.5.1. INCREASE IN OUTPATIENT TREATMENT
2.5.2. SURGE IN MEDICAL WASTE DUE TO THE USE OF DISPOSABLE MEDICAL ITEMS
2.5.3. INSUFFICIENT AWARENESS REGARDING HOSPITAL-ACQUIRED INFECTIONS
2.6. MARKET OPPORTUNITIES
2.6.1. GROWTH OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
2.6.2. RISE IN SURGICAL PROCEDURE RATES
2.6.3. TECHNOLOGICAL ADVANCEMENTS IN PREVENTING SURGICAL SITE INFECTIONS
2.7. ANALYST PERSPECTIVE
3. LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS AND GYNECOLOGY
3.5. WOUND CLOSURE
3.6. PLASTIC & RECONSTRUCTIVE SURGERY
3.7. THORACIC SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER PROCEDURES
4. LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY TYPE OF INFECTION
4.1. SUPERFICIAL INCISIONAL SSI
4.2. DEEP INCISIONAL SSI
4.3. ORGAN OR SPACE SSI
5. LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY SURGICAL CENTERS
6. LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY PRODUCT
6.1. DISINFECTANTS
6.1.1. SKIN DISINFECTANTS
6.1.2. HAND DISINFECTANTS
6.2. MANUAL REPROCESSORS SOLUTIONS
6.3. SURGICAL DRAPES
6.4. SURGICAL GLOVES
6.5. SKIN PREPARATION SOLUTIONS
6.6. SURGICAL IRRIGATION
6.7. SURGICAL SCRUBS
6.8. HAIR CLIPPERS
6.9. MEDICAL NONWOVENS
6.10. OTHER PRODUCTS
7. LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY COUNTRY OUTLOOK
7.1. LATIN AMERICA
7.1.1. COUNTRY ANALYSIS
7.1.1.1. BRAZIL
7.1.1.1.1. BRAZIL SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.2. MEXICO
7.1.1.2.1. MEXICO SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.3. REST OF LATIN AMERICA
7.1.1.3.1. REST OF LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
8. COMPETITIVE LANDSCAPE
8.1. AMERICAN POLYFILM INC
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY STRENGTHS
8.1.4. KEY CHALLENGES
8.2. 3M
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY STRENGTHS
8.2.4. KEY CHALLENGES
8.3. ANSELL LIMITED
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY STRENGTHS
8.3.4. KEY CHALLENGES
8.4. BELIMED LIFE SCIENCE AG
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY STRENGTHS
8.4.4. KEY CHALLENGES
8.5. BECTON, DICKINSON AND COMPANY (BD)
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY STRENGTHS
8.5.4. KEY CHALLENGES
8.6. BIOMERIEUX SA
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY STRENGTHS
8.6.4. KEY CHALLENGES
8.7. GETINGE AB
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY STRENGTHS
8.7.4. KEY CHALLENGES
8.8. GAMA HEALTHCARE
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY STRENGTHS
8.8.4. KEY CHALLENGES
8.9. JOHNSON & JOHNSON
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY STRENGTHS
8.9.4. KEY CHALLENGES
8.10. SOTERA HEALTH LLC
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY STRENGTHS
8.10.4. KEY CHALLENGES
8.11. KIMBERLY-CLARK CORPORATION
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY STRENGTHS
8.11.4. KEY CHALLENGES
8.12. STERIS CORPORATION
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY STRENGTHS
8.12.4. KEY CHALLENGES
8.13. STRYKER CORPORATION
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY STRENGTHS
8.13.4. KEY CHALLENGES
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 2: LIST OF PRODUCT LAUNCHES
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 5: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 6: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 7: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 8: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 9: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2023 & 2032 (IN %)
FIGURE 3: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $ MILLION)
FIGURE 4: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 5: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 6: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 7: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $ MILLION)
FIGURE 8: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 9: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 10: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 11: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 12: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $ MILLION)
FIGURE 13: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $ MILLION)
FIGURE 14: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2023 & 2032 (IN %)
FIGURE 15: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 16: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 17: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $ MILLION)
FIGURE 18: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2023 & 2032 (IN %)
FIGURE 19: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 20: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 21: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 22: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 23: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2023 & 2032 (IN %)
FIGURE 24: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 25: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 26: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 27: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $ MILLION)
FIGURE 28: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $ MILLION)
FIGURE 29: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 30: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $ MILLION)
FIGURE 31: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $ MILLION)
FIGURE 32: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $ MILLION)
FIGURE 33: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $ MILLION)
FIGURE 34: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 35: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 36: BRAZIL SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 37: MEXICO SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 38: REST OF LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)